Earlier this year, the city becamethe first in the country to license sales reps, whose licenses can be revoked if their activities are deemed fraudulent. The bill was passed in hopes of enforcing good business practices on people who have undue influence over docs, and therefore patients.
Now, Washington DC's health department has issued its proposed regulations in order to implement the SafeRx Amendment Act of 2008. For those wondering about the price tag - a license will cost $175 and the biennial renewal fee will be $165.
Here are a few highlights: Operating without a license may generate fines up to $10,000; reps must have graduated from an institution of higher education, although waivers may be granted for anyone who can prove they detailed for at least 12 months prior to March 2008; reps must adhere to a code of ethics, which prohibits gifts and harassing healthcare professionals; and reps participate in continuing ed classes to renew a license. Read it about here.
Hat tip to FDA Law blog